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ABSTRACT Metabolism plays an important role in the persister phenotype, as evidenced by the number of strategies that perturb
metabolism to sabotage this troublesome subpopulation. However, the absence of techniques to isolate high-purity populations
of native persisters has precluded direct measurement of persister metabolism. To address this technical challenge, we studied
Escherichia coli populations whose growth had been inhibited by the accumulation of the MazF toxin, which catalyzes RNA
cleavage, as a model system for persistence. Using chromosomally integrated, orthogonally inducible promoters to express MazF
and its antitoxinMazE, bacterial populations that were almost entirely tolerant to fluoroquinolone and -lactam antibiotics
were obtained uponMazF accumulation, and these were subjected to direct metabolic measurements. While MazFmodel per-
sisters were nonreplicative, they maintained substantial oxygen and glucose consumption. Metabolomic analysis revealed accu-
mulation of all four ribonucleotide monophosphates (NMPs). These results are consistent with aMazF-catalyzed RNA futile
cycle, where the energy derived from catabolism is dissipated through continuous transcription andMazF-mediated RNA degra-
dation.When transcription was inhibited, oxygen consumption and glucose uptake decreased, and nucleotide triphosphates
(NTPs) and NTP/NMP ratios increased. Interestingly, the MazF-inhibited cells were sensitive to aminoglycosides, and this sensi-
tivity was blocked by inhibition of transcription. Thus, in MazFmodel persisters, futile cycles of RNA synthesis and degradation
result in both significant metabolic demands and aminoglycoside sensitivity.
IMPORTANCE Metabolism plays a critical role in controlling each stage of bacterial persistence (shutdown, stasis, and reawaken-
ing). In this work, we generated an E. coli strain in which the MazE antitoxin andMazF toxin were artificially and independently
inducible, and we used this strain to generate model persisters and study their metabolism.We found that even though growth
of the model persisters was inhibited, they remained highly metabolically active. We further uncovered a futile cycle driven by
continued transcription andMazF-mediated transcript degradation that dissipated the energy derived from carbon catabolism.
Interestingly, the existence of this futile cycle acted as an Achilles’ heel for MazFmodel persisters, rendering them vulnerable to
killing by aminoglycosides.
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Bacterial persisters were first described by J. W. Bigger over70 years ago, and these phenotypic variants have since been
documented for a wide range of microbial species treated with
many different antibiotics (1, 2). Despite garnering less attention
than antibiotic resistance, persistence is of considerable clinical
concern, as persisters contribute to antibiotic failure and relapse
of infections and serve as a reservoir from which resistant strains
could emerge (1, 3–6). Unlike resistant bacteria, persisters arise in
an isogenic population and generally do not grow in the presence
of antibiotics (7), although exceptions have been noted for prod-
rugs that require activation (8). Rather, they are rare phenotypic
variants that can subsist during treatment with high antibiotic
concentrations. Once the course of treatment terminates, persist-
ers can exit this transient state, resume growth, and give rise to
progeny that exhibit the same antibiotic sensitivity as the parent
(6, 7).
Persisters were traditionally thought to arise from slowly grow-
ing or nongrowing bacteria with reduced metabolic activity,
where antibiotic targets are inactive and resilient to antibiotic cor-
ruption (1). In recent studies, our group and others have shown
that a number of metabolic pathways remain functional during
persistence, allowing persisters to generate proton motive force
upon consumption of differentmetabolites (9–12).Metabolism is
an important regulator in bacterial persisters (reviewed in refer-
ences 13 and 14), as demonstrated by the number of metabolic
genes (15–18) and metabolic stresses (19–21) involved in their
formation. In particular, persistence can be framed as a metabolic
program, where coordinated metabolic shutdown, maintenance,
and reactivation drive the entry into, subsistence of, and exit from
this transient nonreplicative state (14). Given the central role of
metabolism in bacterial persistence, it is not surprising that a
number of antipersister strategies that have been developed exert
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their effects by targeting metabolism (9–11, 22, 23). For instance,
onemethod involves stimulation of persisters with specific carbon
sources that promote protonmotive force generation, which leads
to aminoglycoside uptake and persister killing (9, 10, 12). In an-
other approach, Kim and colleagues identified a compound
through a chemical screen that could stimulate the reversions of
persisters to a replicating state and promote fluoroquinolone kill-
ing (23). These strategies further emphasize the potential and ne-
cessity of understanding persister metabolism in the development
of novel methods for their effective elimination.
One major hurdle impeding research in persister metabolism
is the lack of a robust isolation method that can segregate persist-
ers from other cell types, specifically, viable but nonculturable
cells (VBNCs), and yield highly pure samples of native persisters
for direct metabolic measurements (9, 24–26). As persistence is a
rare and transient phenotype, which is lost upon growth resump-
tion, culturing of survivors does not yield persister populations
(7). A number of attempts to isolate native persisters have been
described, including methods based on -lactam (27) or che-
moenzymatic lysis of nonpersisters (28) and the use of fluorescent
growth reporters to segregate fast-growing cells from their dor-
mant kin (29). Although some of these methods succeeded in
providing persister-enriched populations, those populations were
not of sufficient purity for measurements to be solely reflective of
persister physiology (9, 25). To circumvent these isolation chal-
lenges, researchers have used methods to produce “synthetic” or
“model” persisters, such as overexpressing toxins, which have
been implicated as terminal effectors of the persister phenotype
(19, 30–32), or treating bacterial cultures with chemical inhibitors
(33) to increase the abundance of persister-like cells in a popula-
tion. These persister analogs can then be subjected to transcrip-
tome, proteome, or metabolome analyses, to study antibiotic-
tolerant states that mimic persistence.
Among the genes that are linked to persistence is a subset
known to encode toxin-antitoxin (TA) modules, which are dis-
tributed across diversemicrobial genomes (reviewed in references
34 and 35). These ubiquitous two-component systems consist of a
stable protein toxin and a labile antitoxin, which may be an RNA
or a protein, with the exception of ppGpp-SpoT, which comprises
a new type of module where a metabolic network exhibits TA
properties (19). Antitoxins can either inhibit the production of
their cognate toxins or antagonize their activities. The TA systems
identified to date are classified based on the nature of antitoxins
and mechanism by which they inhibit their cognate toxins (36).
Each toxin can also target different cellular components, includ-
ing RNAs, enzymes, and the inner membrane, ultimately leading
to growth inhibition (35). Although the biological roles of most
TAmodules remain unclear, many are emerging as key stress reg-
ulatory elements and terminal effectors of persistence (reviewed
in references 37 and 38).MazEF is a type II TA system inwhich the
proteinaceous MazF toxin is sequestered by the MazE protein an-
titoxin in the off state (39). When MazF is liberated from MazE
sequestration, it acts as an endoribonuclease, cleaving target RNAs
at ACA sites (40) and inhibiting protein synthesis (41). The activ-
ity of MazF has been implicated in two opposing cell fates: pro-
grammed cell death (39, 42) and reversible growth stasis and en-
hanced persistence (43, 44).
In an earlier study, Bokinsky and colleagues overexpressed
HipA, another type II toxin, to produce -lactam tolerant model
persisters, which could be used for metabolite quantification, as
well as glucose uptake and oxygen consumption measurements
(30). Given that MazF production has also been linked to persis-
tence (31, 44), we sought to generate model persisters with MazF
accumulation for metabolic measurements. We synthesized an
Escherichia coli strain in which the expression of mazE and mazF
could be orthogonally induced from the chromosome. We dem-
onstrated that when MazF was produced in amounts exceeding
that of MazE, reversible stasis was achieved and treatment of the
population with -lactam and fluoroquinolone antibiotics did
not result in significant killing. When we quantified the metabo-
lism of the MazF persisters, we found that cells maintained im-
pressive oxygen consumption and glucose uptake during growth
stasis, which was suggestive of an increase in futile cycling. When
metabolomic analyses of MazF persisters were performed, we ob-
served high NMP levels, which provided evidence for RNA futile
cycling in these model persisters. In consideration of the meta-
bolic data and themode of action ofMazF, we hypothesized that a
macromolecular futile cycle was formed where energy was con-
sumed by transcription only for the transcripts to be degraded by
MazF. In support of this hypothesis, we observed reductions in
oxygen consumption, glucose uptake, and NMP abundance in
conjunction with increases in NTP abundance with transcrip-
tional inhibition, but not translational inhibition. We also inves-
tigated the possible consequences of maintaining this RNA futile
cycle on persister antibiotic tolerance, and discovered that contin-
ued transcription sustained sufficient translational activity to ren-
derMazF-inhibited cells susceptible to killing by aminoglycosides
(AGs).
RESULTS
MazF accumulation results in reversible growth stasis and en-
hanced antibiotic tolerance.Motivated by the therapeutic poten-
tial of targeting persister metabolism and the isolation challenges
associated with obtaining native persister cells, we sought to gen-
erate a population of model persisters with MazF accumulation
and examine the metabolic program of this type of persister. To
produce E. coli strains with an orthogonally controlled mazE-
mazF expression system and to prevent phenotypic heterogeneity
attributed to plasmid copy number variation, we replaced endog-
enousmazEF with inducible copies integrated at two distinct loci
of the chromosome (see Fig. S1A to D in the supplemental mate-
rial). In this design,mazE is controlled by PBAD, and its expression
is inducible with arabinose (Ara), while mazF is regulated by
PLtetO1 (45) and is inducible with anhydrotetracycline (aTc). To
mimic changes in gene expression that naturally lead to the accu-
mulation ofMazF in E. coli, we inducedmazE expression with Ara
at the time of inoculation, and aTc was added after approximately
one doubling to inducemazF. This allowed the toxin to be seques-
tered by the antitoxin as it was expressed, thereby preventing
growth inhibition and allowing cells to enter the exponential
phase of growth. Once cells were in exponential phase, cells were
diluted in medium with only aTc, allowing MazF to be accumu-
lated in excess of MazE. As a control, an identical aliquot of cells
was diluted in medium with aTc and Ara to allow TA coexpres-
sion.
We observed that the accumulation ofMazF in excess of MazE
resulted in growth inhibition after 2 h, whereas cells expressing
bothMazE andMazF continued to grow (Fig. 1A and B; note that
the increase in optical density at 600 nm [OD600] but lack of in-
crease in CFU forMazF-accumulating culturesmost likely reflects
Mok et al.
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the reduced temporal resolution and accuracy of CFU measure-
ments, which is supported by flow cytometry-based cell counting,
where numbers of cells per milliliter and CFU per milliliter never
differed significantly [see Fig. S2A in the supplemental material]).
Similarly, dilution of E. coliMO::mazE, which lacks PLtetO1-mazF,
in medium with only aTc did not result in growth inhibition,
demonstrating that stasis was dependent on MazF accumulation
(see Fig. S2B in the supplemental material). These results demon-
strated that toxin overexpression in our system led to reversible
growth stasis without reducing culturability, which is consistent
with some previous studies of MazF (31, 43, 44).
We then examined the impact of MazF accumulation on per-
sistence toward antibiotics from two distinct classes: ampicillin
(Amp; a cell wall biosynthesis inhibitor) and ofloxacin (Ofl; a
DNA gyrase inhibitor). To ensure that the cells had achieved
growth stasis at the time of the assay, persister measurements of
the MazF-accumulating samples were taken 4 h following the di-
lution in aTc-supplemented medium. MazE-MazF-expressing
samples were taken 3 h following dilution, so that their densities
were comparable to those of the MazF samples. With the MazE-
MazF samples, we observed biphasic killing following treatment
with both Amp and Ofl, which resulted in reductions in numbers
of CFU per milliliter of approximately 4 orders of magnitude
(Fig. 1C and D). Importantly, MazF samples exhibited tolerance
to Amp and Ofl that approached 100%, with CFU counts before
and after 5 h of individual antibiotic treatments being approxi-
mately equivalent and not statistically significantly different.
These observations confirmed that the vast majority, if not all, of
MazF-accumulating cells were Amp and Ofl persisters.
MazF persisters continue to consume oxygen and glucose
during growth stasis.Native persisters predominantly arise from
dormant, nongrowing subpopulations, yet they retain metabolic
activity, as demonstrated by the consumption of an array of car-
bon sources to drive respiration and produce protonmotive force
(9, 10). Here, we sought to elucidate themetabolic capacity of cells
undergoing MazF accumulation by quantifying their oxygen and
glucose consumption as they entered and remained in toxin-
induced bacteriostasis. To measure the dissolved oxygen in cell
cultures, cells were cultured in a bioreactor, in whichMazE-MazF
samples were able to grow and MazF-accumulating samples
achieved stasis within 2.5 to 3 h of the initiation ofMazF accumu-
lation, which was similar to results obtained from flasks (Fig. 2A).
We observed that MazF and MazE-MazF samples initially con-
sumed oxygen at comparable rates (Fig. 2B). With the onset of
toxin-induced growth inhibition, total oxygen consumption in
theMazF-accumulating culture decreased, and a similar trendwas
observed for glucose consumption (Fig. 2C). However, total oxy-
gen consumed relative to glucose consumed in MazF-arrested
cells was ~50% higher than that in the coexpression control
(Fig. 2D). Further, oxygen consumption relative to biomass pro-
FIG 1 Growth, culturability, and persistence of E. coliMO::mazE-mazF. E. coliMO::mazE-mazF was cultured in growth medium supplemented with aTc and
Ara for MazE-MazF coexpression (blue lines) or with only aTc to facilitate MazF accumulation (red lines). Accumulation of MazF in excess of MazE resulted in
bacteriostasis, as determined by OD600 measurements (A) and CFU counts (B). OD600 and CFU counts between these cells and the MazE-MazF coexpression
control were significantly different at 4 h (*, P 0.05).When amajority of cells in theMazF-accumulating populations were in a reversible growth-arrested state
(4 h after MazF accumulation), significant killing from treatment with Amp (C) and Ofl (D) was not observed, demonstrating that MazF-induced growth arrest
produced model persisters. In comparison, the MazE-MazF coexpression control was susceptible to both antibiotics and exhibited biphasic killing.
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duction (29,892  5,051 M/OD unit produced) was 2.8-fold
higher than the normally growingMazE-MazF control (10,592
688 M/OD unit produced) (Fig. 2E), and glucose consumption
per biomass produced during MazF-induced growth inhibition
(14,368 2,070M/ODunit produced) was 1.9-fold higher than
that of the MazE-MazF control (7,613 739 M/OD produced)
(Fig. 2F). Results from these experiments demonstrate that during
MazF-induced shutdown, cells continued to consume oxygen and
glucose without producing much biomass, and a higher propor-
tion of glucose consumed was catabolized to drive respiration,
which is the main consumer of oxygen under the conditions used
here (46). This inefficient use of energy is a hallmark of cells un-
dergoing increased futile cycling (47, 48).
MazF accumulation depresses cellular energy levels. To fur-
ther investigate the metabolic changes in cells during toxin-
induced shutdown, we analyzed the metabolomes of MazF-
accumulating cells by liquid chromatography-mass spectrometry
(LC-MS) (see Fig. S3 in the supplementalmaterial) (49).We com-
pared the abundance of metabolites extracted from MazF-
accumulating cells with that of metabolites extracted from cells
coexpressingMazE-MazF to identify themetabolites whose abun-
dance significantly changed as a result of toxin-induced stasis. To
assess whether the addition of aTc or Ara impacted the metabo-
lome, we additionally extracted metabolites from E. coli MO::
mazE treated with aTc, which resulted in no protein induction, or
with aTc and Ara, which induced MazE. To capture MazF-
accumulating cells during their transition from a growing state to
a nongrowing state, samples were collected 2, 3, and 4 h following
dilution into medium supplemented with the appropriate induc-
ers.
As cells entered MazF-induced growth stasis, we observed the
most striking changes in the abundance of nucleotides (see Fig. S3
in the supplemental material). For each strain, we calculated the
ratios of the abundances of ribonucleotides from cells treatedwith
aTc to those from cells treated with both aTc and Ara (i.e., unin-
duced/MazE for E. coli MO::mazE and MazF/MazE-MazF for
FIG 2 Quantification of oxygen and glucose consumption in MazF model persisters. E. coli MO::mazE-mazF was grown to exponential phase before being
washed and diluted inGutnickwith 2mMglucose supplementedwith aTc forMazF accumulation (red lines) or aTcwith Ara forMazE-MazF coexpression (blue
lines) at 0 h. (A) Growth of E. coli accumulating MazF or both MazE and MazF in the bioreactor where oxygen measurements were performed. (B) Oxygen
consumption of cells accumulating MazF or expressing MazE-MazF measured over 5 h following inoculation in the bioreactor. The equilibrium oxygen
concentration of themediumwas 210M(dashed line). Cells undergoingMazF-mediated growth inhibition continued to consume oxygen, as illustrated by the
concentration of dissolved oxygen in the growthmedium remaining below 210M. (C)Glucose consumption of cells accumulatingMazF orMazE-MazF. In the
MazF samples, glucose consumption continued during growth inhibition. In the MazE-MazF sample, glucose exhaustion occurred around 4.5 h, and the
cessation of glucose consumption coincided with an increase in dissolved oxygen in the growth medium. (D) Oxygen consumed per glucose consumed was
calculated using data points from 2.5 to 5 h. Cells accumulating MazF consumed ~50%more oxygen per glucose compared with the MazE-MazF coexpression
control. (E) Oxygen consumed relative to biomass produced was calculated using data points from 2.5 to 5 h, and it was 2.8-fold higher in MazF-inhibited cells
than in cells expressingMazE-MazF. (F) Glucose consumed relative to biomass produced (calculated using data points from 2.5 to 5 h) was 1.9-fold higher than
that of the coexpression control. *, P 0.05.
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E. coli MO::mazE-mazF). We observed that in MazF-
accumulating cells, the abundance of all 4 nucleotide monophos-
phates (NMPs) increased 5- to 9-fold over time (Fig. 3). Further-
more, we detected increases in nucleotide diphosphates (NDPs).
Although statistically significant increases in someNTPs were ob-
served, they were all modest compared to the increases in the
NMPs. We note that large changes in NMP or NDP levels do not
have to be accompanied by reciprocal changes in NTP levels, be-
cause the concentrations of NTPs in E. coli are around 10-fold
higher than the concentrations ofNMPs andNDPs (50). InMazF-
accumulating cells, the relative increases in NMPs andNDPs were
higher than those of their NTP counterparts, which translates to a
lower energy charge, as classically defined by the expression
([NTP] 0.5[NDP])/([NTP] [NDP] [NMP]) (51). The el-
evation in NMPs and NDPs complemented the oxygen and glu-
cose consumption data (Fig. 2) in supporting the hypothesis of
increased futile cycling in MazF-inhibited cells (47, 48). As MazF
is an endoribonuclease, which cleaves target transcripts at ACA
sites (40), we hypothesized that the abundance of NMPs, which
was coincident withMazF-mediated growth arrest, was a result of
continued transcription followed by RNA degradation, where
NMPs are the directmolecular products. As depicted in Fig. 4, this
would result in a macromolecular (transcription/transcript deg-
radation) futile cycle, where energy is expended without produc-
ing a gain in biomass.
Transcriptional inhibition reduces oxygen and glucose con-
sumption. To test the above hypothesis and determine whether
transcription is a major energy sink in MazF-inhibited cells, we
inhibited transcriptionwith Rif andmeasured oxygen and glucose
consumption thereafter. Cells were also treated with spectinomy-
cin (Spec) and KCN to compare the effects of translational inhi-
bition and electron transport chain inhibition with those of tran-
scriptional inhibition. When MazF-accumulating cells were
treated with Rif, oxygen consumption decreased rapidly, reaching
a new steady state within 30 min (Fig. 5A). This pattern of rapid
inhibition of oxygen consumption qualitatively mirrored that of
cells treated with KCN, which inhibits cytochrome oxidase activ-
ity (Fig. 5B). As MazF already reduces protein synthesis through
cleavage of both mRNA and rRNA (40, 52), inhibiting translation
with Spec did not and was not expected to reduce oxygen con-
sumption (Fig. 5C). Rif also transiently decreased glucose con-
sumption (Fig. 5D). Combined, these results suggested that RNA
polymerase activity is a driving force for energy consumption in
MazF-inhibited cells, which supported the hypothesis that MazF
accumulation initiated an RNA futile cycle.
Transcriptional inhibition impedes MazF-dependent de-
pression of cellular energy levels. We investigated the effect of
Rif and Spec treatment on the nucleotide pools in MazF-
accumulating cells (Fig. 6). In the case of the purine nucleotides,
we observed significant decreases in AMP, ADP, GMP, and GDP
levels in Rif-treated, MazF-accumulating cells compared with the
untreated control, whereas the abundances of ATP and GTP in-
creased 2.5- and 6-fold, respectively. In contrast, treatment with
Spec did not significantly alter the abundances of any purine nu-
cleotide in comparison to the untreated control. For uridine nu-
cleotides, a largely similar pattern was observed, except that UDP
levels in Rif-treated samples were not significantly different from
those of the untreated control. However, cytosine nucleotides had
a distinct pattern, where Rif treatment significantly increased the
abundance of CMP, CDP, and CTP compared to untreated con-
trols, whereas Spec treatment changed them very little. Although
the origin of this metabolic perturbation of cytosine nucleotides
was not determined here, we did find that significant accumula-
tion of cytosine nucleotides also occurred in Rif-treated E. coli
MO::mazE induced with aTc, whereas the other Rif-dependent
nucleotide perturbations in MazF-accumulating cells were not
observed (see Fig. S4 in the supplemental material). These data
suggested that the changes in cytosine nucleotide levels originated
from a Rif-dependent phenomenon that was independent of
MazF, whereas the changes in purine and uridine nucleotide levels
reflected an interaction betweenMazF and transcriptional inhibi-
tion.Overall, NTP/NMP ratioswere greatly increased byRif for all
nucleotides, which provides further support for the idea that
MazF accumulation depressed energy levels through a futile cycle
driven by RNA polymerase (RNAP) and the toxin’s endoribonu-
clease activity.
Effect of futile cycle inhibition on antibiotic tolerance. To
further study the impacts of the transcription/RNA degradation
futile cycle, we examined the effect of inhibiting this cycle on tol-
erance of different classes of antibiotics (Fig. 7). When Rif-treated
cells were plated, we observed ~10-fold fewer CFU than their un-
treated counterparts at time zero, and CFU counts increased
throughout the course of the 5-h assay. These changes in CFU
were observed even in the absence of subsequent antibiotic treat-
ment (Fig. 7A), suggesting that they were Rif dependent. These
changes in CFU counts could be due to a fraction of the popula-
tion being killed immediately fromRif treatment followed by rep-
lication of the surviving population over the next 5 h, or alterna-
tively, the increase in CFU could be attributed to cells regaining
culturability over time. To determine which of the two mecha-
nisms was behind the changes in CFU counts observed in Rif-
treated cells, we used the IPTG-inducible copy of the mCherry
gene integrated in place of lacZYA in E. coliMO::mazE and E. coli
MO::mazE-mazF as a cell division reporter (53). IPTG was added
to induce expression of the mCherry gene at the same time as aTc
addition, when cells were being cultured from lag phase to early
exponential phase. When cells reached an OD600 of 0.1, they were
pelleted and washed before being diluted in fresh medium,
thereby removing the IPTG. We then monitored changes in red
fluorescence in these cells before and after Rif treatment using
flow cytometry. If the cells were dividing, mCherry would be dis-
tributed among the daughter cells, and a reduction in the mean
fluorescence of the population would be observed over time (53).
If the cells were regaining culturability after Rif treatment, dilu-
tion of red fluorescence would not be observed.
We measured the fluorescence of the population at 3 h, which
was just before Rif treatment. Samples were also measured at 4 h
and 9 h, which correspond to 0 h and 5 h of persister assays. In cells
accumulating MazF, we observed that the mean fluorescence of
the population decreased to ~40% in 4 h as cells divided before
reaching a plateau as growth was inhibited by MazF. The mean
fluorescence of the population then remained at ~30% (see
Fig. S5A in the supplemental material). In E. coli accumulating
MazF treated with Rif, the decrease in red fluorescence also
reached a plateau by 4 h and remained at ~30%by 9 h (see Fig. S5B
in the supplemental material). As a control, we monitored the
growth and fluorescence of E. coli MO::mazE, and we observed
that this population, which grew exponentially, displayed a sig-
moidal decline in mean population fluorescence and approached
0% by 6 h (see Fig. S5C in the supplemental material). When this
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FIG 3 Quantification of ribonucleotide pools in MazF model persisters during growth stasis. E. coli MO::mazE and E. coli MO::mazE-mazF were grown to
exponential phase before being washed and diluted in Gutnick-glucose medium supplemented with aTc or aTc and Ara, which represents 0 h. Samples were
collected and extracted 2, 3, and 4 h postdilution. Ratios of ribonucleotides in E. coli MO::mazE and E. coli MO::mazE-mazF were calculated by dividing the
OD600-normalized abundances in aTc-induced cells by the OD600-normalized abundances in aTc and Ara-induced cells collected from the same experimental
replicate. Averages and standard errors of the means (SEM) of ratios calculated from four experiments are shown. Ratios derived from E. coliMO::mazE-mazF
were compared with ratios derived from E. coli MO::mazE (*, P  0.05). Overall, MazF accumulation resulted in statistically significant increases in all four
ribonucleotide monophosphates. Greater relative increases in the abundances of NMPs and NDPs compared with their NTP counterparts are suggestive of low
energy levels in MazF-accumulating cells.
Mok et al.
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population was treated with Rif 3 h postdilution, the decrease in
fluorescence slowed, reached a plateau by 4 h, and remained at
~25% (see Fig. S5D in the supplemental material). These obser-
vations suggest that if theRif-treated sampleswere to grow10-fold
in 5 h, it should present as an almost complete loss of fluorescence,
similar to the decline observed with the MazE control between 3
and 7 h. The lack of decrease in mean population fluorescence
demonstrates that the increase in CFU observed in Rif-treated
samples was not due to growth in the presence of antibiotics but
was rather a result of cells regaining culturability over time.
While transcription inhibition with Rif affected culturability
soon after treatment, it did not alter the tolerance of MazF-
accumulating cells to Amp (Fig. 7B) and Ofl (Fig. 7C), as Rif-
treated and untreated samples produced comparable CFU counts
after 5 h of antibiotic exposure. While MazF acts as an endoribo-
nuclease, cells accumulating MazF have been shown to retain
some translational activity, being able to translate synthetic
mRNAs devoid of the ACA recognition sequence as well as a sub-
set of native transcripts (41, 54). Although rRNAs are protected
from extensive degradation by structures and ribosomal proteins,
Vesper and colleagues found that the anti-Shine-Dalgarno se-
quence of the 16S rRNAwas susceptible toMazF cleavage, thereby
producing “stress ribosomes” that favor the translation ofmRNAs
lacking the leader sequence upstream of their start codons (52).
Consistent with these findings, we observed that cells accumulat-
ing MazF could transcribe and translate the IPTG-inducible
mCherry gene during stasis, producing fluorescent cells (see
Fig. S6A in the supplemental material). This evidence of transla-
tional activity in MazF-arrested cells led us to investigate their
sensitivity to kanamycin (Kan) and streptomycin (Strep), bacte-
ricidal members of the AG class of antibiotics, which target the
aminoacyl-tRNA site and decoding center of the ribosome, re-
spectively, and cause mistranslation (55–57). Unlike Amp and
Ofl, E. coli accumulating MazF was as sensitive to Kan (Fig. 7D)
and Strep (Fig. 7E) as E. coliMO::mazE, with numbers of CFU per
milliliter decreasing by 4 to 5 orders of magnitude. When tran-
scriptionwas inhibited with Rif, which inhibited protein synthesis
at an upstream step, protein synthesis was significantly reduced
(see Fig. S6A in the supplemental material) and AG-enabled kill-
ingwas no longer observed (Fig. 7D andE). To determinewhether
a perturbation of proton motive force contributed to AG toler-
ance upon Rif treatment, we used DiBAC4(3) to quantify mem-
brane potential () (58). We note that at neutral pH, the domi-
nant component of protonmotive force, which is themain driving
force for AG uptake, is  (59, 60). Consistent with previous
reports, we observed that  was not diminished with Rif treat-
ment (see Fig. S6B in the supplemental material) (61). Inhibiting
RNAP activity with Rif in the E. coli MO::mazE control also con-
ferred tolerance to Kan and Strep along with Ofl and Amp (see
Fig. S7 in the supplemental material), which is consistent with a
previous report (33). Thus, in MazF-inhibited cells, the residual
translational activity that occurs as a result of operation of the
RNA futile cycle (continued transcription in the face of MazF-
mediated RNAdegradation) (Fig. 4) is sufficient to support killing
by aminoglycosides, and inhibition of the futile cycle at RNAP
serves to expand the antibiotic tolerance profile of this type of
persister.
DISCUSSION
Understanding persister metabolism is anticipated to produce
novel targets for persister elimination (10, 14, 23), yet the absence
of an effective method to isolate pure native persisters has pre-
vented direct metabolic measurements and hindered progress in
this area of research (9).With toxins of TAmodules being increas-
ingly identified as terminal effectors of the persister phenotype
(34, 35), efforts have been made to achieve growth inhibition and
antibiotic tolerance in bacteria with toxin overexpression (19, 31,
38, 62), which has allowed the metabolism of these model persist-
ers to be assessed (30). The formation of native persisters has been
proposed to involve multiple TA modules; thus, the activation of
different TA modules has been postulated to contribute to the
heterogeneity in persister populations (63). In this study, we
sought to interrogate the metabolic program of persisters, and in
the absence of methods to isolate native persisters to high purity,
we relied upon MazF accumulation to produce a model system
representative of one type of persister and analyzed its metabolic
state. Consistent with several published reports, MazF accumula-
tion inE. coliMO::mazE-mazF, wheremazE andmazFwere placed
under the orthogonal control of two inducible promoters, re-
sulted in reversible growth stasis without significant killing or loss
of culturability (31, 43, 44). Furthermore, we observed enhanced
persistence in the presence of fluoroquinolone and -lactam an-
tibiotics, as the resulting population could not be killed by Ofl or
Amp (31, 44).
When extracellular metabolite consumption of MazF-
inhibited cells was measured, we found that they, like cells inhib-
ited by the HipA toxin examined previously (30), maintained ac-
tive oxygen consumption and glucose uptake despite a significant
reduction in biomass production. In fact, the oxygen and glucose
consumption per biomass and amount of glucose consumed to
drive respiratory activity all increased in cells undergoing MazF-
FIG 4 MazF-induced transcription/transcript degradation macromolecular
futile cycle. (Step 1) Transcription mediated by RNAP is hypothesized to con-
tinue in MazF model persisters. (Step 2) Hydrolysis of pyrophosphates by
inorganic pyrophosphatase (PPase) provides thermodynamic pull for RNA
synthesis. (Step 3) RNAs are cleaved byMazF. (Step 4) Various RNases further
degrade cleaved RNA (RNAcleaved), leading to NMP accumulation. (Step 5)
Nucleotide kinases and synthases catalyze the phosphorylation of NMPs to
produce NTPs, which is a process that consumes energy.
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induced growth inhibition compared with the MazE-MazF coex-
pression control, which was suggestive of futile use of resources
(47, 48). When we analyzed the metabolomes of MazF-
accumulating cells, we observed increased relative abundances of
NMPs and NDPs compared with NTPs, which suggested that the
energy level in these cells was reduced and provided additional
evidence for enhanced futile cycling. The endoribonuclease activ-
ity of MazF led us to postulate that RNAP and MazF oppose each
other’s functions and establish an RNA (transcription/transcript
degradation) futile cycle (Fig. 4). When we inhibited RNAP activ-
ity with Rif, we observed reductions in glucose and oxygen con-
sumption, decreases in the abundance of most NMPs, and in-
creases in the abundances of NTPs, which provided further
support for the proposed futile cycle. We postulate that this futile
cycle may function to continue synthesis of ribosomal RNAs,
MazE, and other proteins (41), which could enable cells to over-
come the inhibitory effects of MazF and resume growth rapidly.
Interestingly, the RNA futile cycle gives MazFmodel persisters
an Achilles’ heel. This cycle sustains aerobic respiration, which
maintains an electrical potential () across the innermembrane,
enabling AG uptake (see Fig. S6B in the supplemental material).
Despite the function of MazF as an endoribonuclease, these cells
retain residual protein synthesis, which renders this quasidormant
population susceptible to killing by AG. Sensitivity to AGs in cells
that are tolerant to quinolones and -lactams has been well doc-
umented in native persisters (9, 10, 20, 24, 44, 64), and this points
to a physiological parallel between theMazFmodel persisters used
here and their native counterparts. Taken together with evidence
that endoribonuclease toxins cross-activate (65) and are also in-
tegral to persister formation mediated by HipA (38), this macro-
molecular futile cycle, though found in MazF model persisters,
may be a hallmark of cells undergoing growth arrest mediated by
endoribonuclease toxins. As RNAs are cleaved, the toxin-arrested
cells may attempt to counteract this catastrophic effect by replen-
ishing RNAs, which produces a significant energy draw on the
system. Metabolic analysis of model persisters generated with the
accumulation of other type II endoribonuclease toxins are needed
to determine whether this futile cycle is a common phenomenon.
In this study, we used MazF model persisters to investigate
metabolic processes that remain active during shutdown and en-
try into a growth-inhibited, antibiotic-tolerant state. Metabolism
in other stages of the persister metabolic program, such as the
metabolic activities of MazF model persisters during long-term
maintenance in the presence of antibiotics and the sequence of
changes that drive reactivation and reawakening, remains to be
investigated. Here, we showed that inhibiting the RNA futile cycle
expanded the antibiotic tolerance profile of MazF model persist-
ers. This further emphasizes that having a comprehensive view of
the metabolic program of MazF model persisters, along with
knowledge of the metabolic programs in model persisters formed
FIG 5 Effect of transcription and translation inhibitors on oxygen and glucose consumption in E. coli accumulating MazF. E. coliMO::mazE-mazF was grown
to exponential phase and then pelleted, washed, and diluted in Gutnick medium with 2 mM glucose and aTc to induce MazF accumulation at 0 h. Dissolved
oxygen and glucose consumption in the culture were measured in a bioreactor over 5 h. At 3 h postinoculation (red dashed line), inhibitors (100 g/ml Rif,
100 g/ml Spec, or 5 mM KCN) were added to each culture. Top panels compare oxygen consumption and bottom panels compare glucose consumption of
untreated samples with those treated with Rif (A and D), KCN (B and E), or Spec (C and F). Inhibition of transcription in MazF-accumulating cells resulted in
rapid decrease in oxygen consumption, which was similar to results with cells treated with the respiratory inhibitor KCN. Glucose consumption modestly and
transiently decreased only in the Rif-treated sample, whereas cells treated with Spec or KCN exhibited glucose uptake similar to that in the untreated sample. *,
P 0.05.
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FIG 6 Effects of transcription and translation inhibitors on the ribonucleotide pools of MazF persisters. Three hours after E. coliMO::mazE-mazF was diluted
and cultured inGutnick-glucose with aTc to induceMazF accumulation (designated time zero), the samples were treated with no inhibitor, Rif, or Spec. Samples
were then collected hourly for 2 h for LC-MS analysis. Ratios of ribonucleotides in inhibitor-treated samples to those in untreated samples were calculated by
dividing the OD600-normalized abundances in treated samples by the normalized abundances in untreated samples collected from the same experimental
replicate. Averages and SEM of ratios calculated from four experiments are shown. A ratio of 1, indicating no difference between the two samples, is depicted by
the dashed line on each graph, and asterisks indicates statistically significant deviations from a value of 1 (P 0.05). With the exception of CMP, Rif treatment
decreased the abundances of NMPs. In contrast, the abundances of all four NTPs increased. These results suggested that Rif treatment led to the inhibition of the
RNA futile cycle, which consequently increased the energy level of cells.
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with other toxins, will help define the phenotypic landscape of
persisters and shed light on their vulnerabilities.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coliMO::mazE and E. coliMO::mazE-
mazF are derivatives of E. coli MO001 (53), which harbors an inducible
copy of the mCherry gene in place of lacZYA. Additional description and
methods for their construction are provided in Text S1 in the supplemen-
tal material. Bacterial strains, plasmids, and primers for plasmid and
strain construction that were used in this study are presented in Ta-
ble S1 in the supplemental material.
Chemicals and growth medium. Growth medium components, in-
ducers, and antibiotics were purchased from Thermo, Fisher Scientific
(Waltham, MA) or Sigma-Aldrich (St. Louis, MO). Methods for their
preparation are detailed in the Text S1 in the supplemental material.
Overall, we used 100mMAra to inducemazE and 300ng/ml aTc to induce
mazF to ensure high MazF accumulation throughout the course of the
experiments.We also demonstrated that reducing the inducer concentra-
tion to 50 or 150 ng/ml produced comparable growth inhibition and
persister phenotypes (see Fig. S8A to C in the supplemental material).
Culture conditions and growthmeasurements.Unless otherwise de-
scribed, overnight cultures were inoculated from to80°C stocks stored
in 15% glycerol and grown in 2ml of Luria-Bertani (LB)medium in a test
tube with shaking at 250 rpm for 4 h before being diluted (1:100) in 2 ml
of Gutnick medium (66) with 10mM glucose in a test tube and grown for
an additional 16 h. Following overnight growth, cells were diluted in 25ml
of Gutnick-glucose supplemented with 100 mM Ara (to induce mazE in
bothMO::mazE andMO::mazE-mazF) to anOD600 of ~0.01 and grown at
37°C with shaking at 250 rpm. After approximately one doubling, cells
were induced with 300 ng/ml aTc (to induce mazF in MO::mazE-mazF).
When the OD600 of these initial cultures had reached 0.1, 5 ml of cells was
pelleted by centrifugation at 4,000 rpm at 37°C for 10 min. After removal
of 4 ml of supernatant, the pellet was resuspended in the remaining me-
dium and transferred to a microcentrifuge tube, where it was pelleted at
15,000 rpm for 3 min. After removal of the remaining supernatant, the
pellets were washed with prewarmed (37°C) Gutnick-glucose medium
and centrifuged again. The pellets were then resuspended and reinocu-
lated into 25 ml of prewarmed Gutnick-glucose medium supplemented
with either aTc or aTc and Ara to achieve an OD600 of 0.02. At designated
time points, samples were collected for OD600 measurements (measured
using the BioTek SynergyH1multimode reader; Biotek Instruments, Inc.,
Winooski, VT) and CFU enumeration. To enumerate CFU per milliliter,
500 l of samples was collected, and the cells were pelleted by centrifuga-
tion at 15,000 rpm for 3 min. After removal of 450 l of supernatant, the
pellets were washed with 450 l of 1 phosphate-buffered saline (PBS).
Cells were pelleted again by centrifugation, and 400l of supernatant was
removed. The pellets were resuspended in the remaining 100 l of PBS
and transferred to individual wells of a 96-well round-bottom plate.
Ten microliters of each sample was serially diluted in 90 l of PBS, and
10 l of each dilution was spotted onto LB agar plates supplemented
with Ara. The plates were incubated at 37°C for 16 h before CFU were
counted. For each data point, 10 to 100 colonies were counted. Where
indicated, 450 l of washed cells was mixed with 50 l Sphero Accu-
Count fluorescent particles (Spherotech Inc., Lake Forest, IL), and
cells were enumerated using an LSRII flow cytometer (BD Biosciences,
San Jose, CA). Cell populations and fluorescent particles were detected
and distinguished using forward and side scattering parameters, and
the particles were further identified by measuring green fluorescence
FIG 7 Effect of inhibiting the RNA futile cycle on the antibiotic tolerances of MazF persisters. E. coliMO::mazE-mazF was diluted in Gutnick-glucose medium
supplementedwith aTc, cultured for 3 h, and treatedwith no inhibitor or Rif. One hour posttreatment, cells were exposed to no antibiotics (A), Amp (B), Ofl (C),
Kan (D), or Strep (E). Rif treatment caused reduced culturability at time zero, which was regained during the course of the assay (refer to Fig. S6 in the
supplemental material for supporting data). In MazF-accumulating cells, Rif treatment did not alter Amp or Ofl persister levels compared with the untreated
control. However, MazF-accumulating cells were sensitive to Kan and Strep, and an increase in persister levels was observed only when transcription and, as a
consequence, translation were inhibited with Rif treatment.
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(488-nm laser, 525/50-nm band pass filter). Data were acquired and
analyzed using the FACSDiva software.
Persister assay. Overnight cultures were inoculated, cultured, in-
duced, washed, and diluted as described above. At specified time points or
cell densities following dilution in Gutnick-glucose with aTc or aTc and
Ara, 500-l aliquots of culture were transferred into 17- by 100-mmpoly-
propylene test tubes (Thermo, Fisher Scientific), treated with antibiotics,
and incubated at 37°Cwith shaking at 250 rpm.At designated time points,
cells were transferred into microcentrifuge tubes, pelleted by centrifuga-
tion at 15,000 rpm for 3 min, and washed twice with PBS to reduce anti-
biotic concentrations to below their MICs (67). Samples were serially
diluted in PBS, and 10l of each dilution was plated on LB-agar with Ara.
When necessary, the entire 90-l sample was plated in order to improve
the limit of detection. The plates were then incubated at 37°C for 16 h. For
each data point, 10 to 100 colonies were counted following incubation.
Oxygen and glucose consumption assays. When the OD600 of the
initial cultures reached 0.1, 2 ml of culture was transferred to microcen-
trifuge tubes, pelleted by centrifugation (15,000 rpm, 3 min), and washed
with 2ml of warmedmedium (Gutnick with 2mMglucose supplemented
with aTc or aTc and Ara). Oxygen measurements were carried out in a
disposable bioreactor following previously published protocols (47, 68).
Briefly, cells were inoculated in 10 ml of warmmedium in a 50-ml Falcon
tube in which themedium is stirred with a sterilizedmagnetic stirring bar.
The Falcon tube was further immersed in a stirred water bath to maintain
the temperature at 37°C. The concentration of dissolved oxygen wasmea-
sured for 5 husing the FireStingO2fiber-opticO2meterwith anOXF1100
fixed-needle-type minisensor (PyroScience GmbH). The temperature of
the water bath was monitored using the TDIP15 temperature sensor (Py-
roScience GmbH) so that signals from the O2 sensor could be automati-
cally adjusted for temperature fluctuations. We note that the equilibrium
concentration of O2 in the medium in contact with air is ~210 M (47).
Three hours postinoculation, inhibitors, such as Rif, Spec, andKCN, were
added. Every 30 min throughout the course of the experiment, 200 l of
culture was taken for OD600 measurements, and the sample was filtered
using a 0.22-m filter. The filtrates were collected and stored at 20°C
until theywere used for glucosemeasurements, whichweremade using an
Amplex Red glucose/glucose oxidase kit (Life Technologies). Total O2
consumed was calculated using the approach reported by Adolfsen and
Brynildsen (47). The volumetric mass transfer coefficient (kLa) used for
this calculation was determined by purging cell-free Gutnick-glucoseme-
dium with N2 and calculating the slope of the continuous increase in
dissolvedO2 versus time. kLawasmeasured for 8, 9, and 10ml ofmedium
in order to obtain a regression equation [kLa(V)0.7993V 12.707,
whereV is the volumeof culture in the bioreactor and this linear fit yielded
an R2 value of 1] to determine the kLa that was to be used for each data
point as the volume of the culture decreased throughout the course of the
assay due to sampling. Total glucose consumed was calculated by sub-
tracting glucose concentration measured in the filtrate collected at each
time point from2mM(concentration at time zero). To calculate amounts
of oxygen and glucose consumed per biomass, total oxygen or glucose
consumed between 2.5 and 5 h of the assay (onceMazF-mediated growth
inhibition was achieved) was plotted against OD600 measured during that
time, and linear regression was performed to obtain the slopes of the
regression lines.
LC-MSmetabolomic analysis.To extract cellularmetabolites,metab-
olism was quickly quenched by vacuum-filtering 4 ml of culture at desig-
nated time points on nylon membranes (0.45-m pore size) and trans-
ferring these membranes into 60-mm petri dishes containing 1.2 ml of
cold (20°C) extraction solvent (40:40:20 methanol/acetonitrile/H2O,
high-performance liquid chromatography [HPLC] grade). Culture den-
sity at the time of extraction was measured by OD600. After 30 min of
extraction at20°C,membraneswere thoroughlywashedwith extraction
solvent in the dish. The extracts were collected in microcentrifuge tubes
and centrifuged at 15,000 rpm at 4°C for 5min, and 300l of supernatant
from each sample was transferred to new microcentrifuge tubes. To ob-
tain soluble metabolites, the supernatants were dried under N2 gas and
resuspended in HPLC-grade H2O. Samples were analyzed by reversed-
phase ion-pairing liquid chromatography coupled to a stand-alone Or-
bitrap mass spectrometer (Exactive; Thermo Scientific) by negative-ion
mode electrospray ionization (69). Metabolite peaks that matched both
exact mass-to-charge ratios and retention times of authenticated stan-
dards were quantified using MAVEN software (70). Metabolite abun-
dances were normalized to cell density (OD600). Ratios of normalized
ribonucleotide abundances in samples cultured in the presence of aTc to
abundances in samples cultured in the presence of aTc and Ara were
calculated to determine the effect of MazF accumulation. For samples
treated with inhibitors, ratios of normalized ribonucleotide abundances
of treated samples to untreated samples were calculated to assess the im-
pact of inhibitor treatment.
Statistical analysis.At least three biological replicates were performed
for each experimental condition. Where indicated, a two-tailed t test was
performed for pairwise comparisons. P values of0.05 were considered
significant, and each data pointwas represented by themean value and the
standard error.
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